Aryana Arash, d'Avila Andre, Heist E Kevin, Mela Theofanie, Singh Jagmeet P, Ruskin Jeremy N, Reddy Vivek Y
Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA 02114, USA.
Circulation. 2007 Mar 13;115(10):1191-200. doi: 10.1161/CIRCULATIONAHA.106.672162. Epub 2007 Feb 12.
The present study examines the safety and feasibility of using a remote magnetic navigation system to perform endocardial and epicardial substrate-based mapping and radiofrequency ablation in patients with scar-related ventricular tachycardia (VT).
Using the magnetic navigation system, we performed 27 procedures on 24 consecutive patients with a history of VT related to myocardial infarction, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy, or sarcoidosis. Electroanatomic mapping of the left ventricular, right ventricular, and ventricular epicardial surfaces was constructed in 24, 10, and 12 patients, respectively. Complete-chamber VT activation maps were created in 4 patients. A total of 77 VTs were inducible, of which 21 were targeted during VT with the remotely navigated radiofrequency ablation catheter alone. With a combination of entrainment and activation mapping, 17 of 21 VTs (81%) were successfully terminated in a mean of 8.4+/-8.2 seconds; for the remainder, irrigated radiofrequency ablation was necessary. The mean fluoroscopy times for endocardial and epicardial mapping were 27+/-23 seconds (range, 0 to 105 seconds) and 18+/-18 seconds (range, 0 to 49 seconds), respectively. In concert with a manually navigated irrigated ablation catheter, 75 of 77 VTs (97%) were ultimately ablated. Four patients underwent a second procedure for recurrent VT, 3 with the magnetic navigation system. After 1.2 procedures per patient, VT did not recur during a mean follow-up of 7+/-3 months (range, 2 to 12 months).
The present study demonstrates the safety and feasibility of remote catheter navigation to perform substrate mapping of scar-related VT in a wide range of disease states with a minimal amount of fluoroscopy exposure.
本研究探讨使用远程磁导航系统对瘢痕相关性室性心动过速(VT)患者进行心内膜和心外膜基质标测及射频消融的安全性和可行性。
我们使用磁导航系统对24例有心肌梗死、扩张型心肌病、致心律失常性右室心肌病、肥厚型心肌病或结节病相关VT病史的连续患者进行了27次手术。分别对24例、10例和12例患者构建了左心室、右心室和心室心外膜表面的电解剖标测图。4例患者创建了全腔室VT激动标测图。共诱发77次VT,其中21次仅在VT发作时使用远程导航射频消融导管进行靶向消融。结合拖带和激动标测,21次VT中的17次(81%)平均在8.4±8.2秒内成功终止;其余的则需要进行灌注射频消融。心内膜和心外膜标测的平均透视时间分别为27±23秒(范围0至105秒)和18±18秒(范围0至49秒)。与手动导航的灌注射频消融导管配合,最终消融了77次VT中的75次(97%)。4例患者因VT复发接受了第二次手术,其中3例使用了磁导航系统。每位患者平均接受1.2次手术后,在平均7±3个月(范围2至12个月)的随访期间VT未复发。
本研究证明了远程导管导航在多种疾病状态下以最少的透视暴露对瘢痕相关性VT进行基质标测的安全性和可行性。